Our Technology

Stimulated Toll-like Receptor Technology [STaRTTM] emulates nature  by presenting danger-signal mimetics to Toll-like receptors [TLRs]

Applying the STaRT System to mesenchymal stem cells [MSCs] yields a potent anti-tumor MSC1 or anti-inflammatory MSC2 cell type

MSC1 and MSC2 cells migrate to sites of immune dysfunction and exert their therapeutic action via paracrine effects and cell-to-cell contact.

In seven (7) different pre-clinical models of disease, primed MSCs reboot proper immune function via a multi-pronged mechanism of action.